Latest Articles
"Justice after 19 years": Couple awarded KSh 157m in medical negligence case - Tuko News
"Justice after 19 years": Couple awarded KSh 157m in medical negligence case Tuko News
Published: June 5, 2025, 6:04 a.m.
SNUBH study finds lymph node dissection unnecessary in some endometrial cancer cases - koreabiomed.com
SNUBH study finds lymph node dissection unnecessary in some endometrial cancer cases koreabiomed.com
Published: June 5, 2025, 3:23 a.m.
Successful Pregnancy and Delivery After Detecting an Exceptionally Early-Formed Implantation Window Using Endometrial Receptivity Analysis: A Case Report - Cureus
Successful Pregnancy and Delivery After Detecting an Exceptionally Early-Formed Implantation Window Using Endometrial Receptivity Analysis: A Case Report Cureus
Published: June 4, 2025, 11:50 p.m.
Doctor reveals 5 daily diet changes that could help ease painful condition - Bristol Live
Doctor reveals 5 daily diet changes that could help ease painful condition Bristol Live
Published: June 3, 2025, 4:02 p.m.
CBD Life Sciences Inc. (CBDL) Releases New CBD Suppositories for Vaginal & Rectal Relief - Newswire :) Press Release Distribution
CBD Life Sciences Inc. (CBDL) Releases New CBD Suppositories for Vaginal & Rectal Relief Newswire :) Press Release Distribution
Published: June 3, 2025, noon
Doctor reveals 5 daily diet changes that could help ease painful condition - Surrey Live
Doctor reveals 5 daily diet changes that could help ease painful condition Surrey Live
Published: June 3, 2025, 11:01 a.m.
CBD Life Sciences Inc. (CBDL) Releases New CBD Suppositories for Vaginal & Rectal Relief - The Globe and Mail
CBD Life Sciences Inc. (CBDL) Releases New CBD Suppositories for Vaginal & Rectal Relief The Globe and Mail
Published: June 3, 2025, 8 a.m.
From period pain to heart disease, the gender health gap is real — here’s how to close it - Down To Earth
From period pain to heart disease, the gender health gap is real — here’s how to close it Down To Earth
Published: June 3, 2025, 6:12 a.m.
Genmab Announces Investigational Rinatabart Sesutecan (Rina-S®) Demonstrates Encouraging Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer in Phase 1/2 RAINFOL™-01 Trial - BioSpace
Genmab Announces Investigational Rinatabart Sesutecan (Rina-S®) Demonstrates Encouraging Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer in Phase 1/2 RAINFOL™-01 Trial BioSpace
Published: June 2, 2025, 11:48 p.m.
Genmab Announces Investigational Rinatabart Sesutecan (Rina-S®) Demonstrates Encouraging Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer in Phase 1/2 RAINFOL™-01 Trial - GlobeNewswire
Genmab Announces Investigational Rinatabart Sesutecan (Rina-S®) Demonstrates Encouraging Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer in Phase 1/2 RAINFOL™-01 Trial GlobeNewswire
Published: June 2, 2025, 6:32 p.m.
Link copied to clipboard!